Applied Therapeutics, Inc. (Nasdaq: APLT; “Applied”), a clinical-stage biopharmaceutical company dedicated to creating transformative treatments for rare diseases, announces a definitive agreement for Cycle Group Holdings Limited (“Cycle”) to acquire Applied Therapeutics. Applied Therapeutics is a clinical-stage biopharmaceutical company committed to the development of novel drug candidates against validated molecular targets in rare diseases. Applied’s lead drug candidate, govorestat, is a novel central nervous system (CNS) penetrant Aldose Reductase Inhibitor (ARI) for the treatment of CNS rare metabolic diseases.
Read the full article: Cycle Pharmaceuticals to Acquire Applied Therapeutics //
Source: https://www.globenewswire.com/news-release/2025/12/11/3204367/0/en/Cycle-Pharmaceuticals-to-Acquire-Applied-Therapeutics.html?_gl=1*1g312w0*_up*MQ..*_ga*MTkxNzUwOTIzMC4xNzY1NDkzMzYy*_ga_ERWPGTJ5X8*czE3NjU0OTMzNjEkbzEkZzAkdDE3NjU0OTMzNjEkajYwJGwwJGgw